Trichoderonic acids A (1) and B (2), novel terpenoids, and (+)-heptelidic acid (3) isolated from cultures of a fungus, Trichoderma virens, and their structures were identified by spectroscopic analysis. These compounds selectively and competitively inhibited the activities of mammalian DNA polymerases , (pols , ), and terminal deoxynucleotidyl transferase (TdT) in family X of pols, and compound 2 was a stronger inhibitor than compound 1 or 3. On the other hand, compounds 1-3 did not influence the activities of the other families (A-, B-, and the Y-families) of the mammalian pols tested, and showed no effect on the activities of plant pol , fish pol , prokaryotic pol, or the other DNA metabolic enzymes tested. Compound 2 suppressed the growth of two human cancer cell lines, cervix carcinoma cells (HeLa) and breast carcinoma cells (MCF-7). The results suggest that these compounds identified inhibition among the families of mammalian pols.
We have long been interested in the integrity of the genomes of eukaryotes and their relation to cell differentiation. DNA replication, recombination, and repair in eukaryotes are key systems maintaining these processes, 1) and DNA polymerases (pols) have important roles. In this regard, we have concentrated our efforts on investigating the eukaryotic pols associated with these processes.
2)
The human genome encodes at least 15 pols conducting cellular DNA synthesis. 3, 4) Eukaryotic cells contain three replicative pols (, , and "), mitochondrial pol , and at least 11 non-replicative pols (, , , , , , , , , terminal deoxynucleotidyl transferase (TdT), and REV1). [3] [4] [5] Pols have a highly conserved structure, which means that their overall catalytic subunits vary on the whole very little among species. Conserved structures usually indicate important, irreplaceable functions of the cell, the maintenance of which provides evolutionary advantages. Based on sequence homology, eukaryotic pols can be divided into four main families, A, B, X, and Y. 6) Family A includes mitochondrial pol and pols and , and family B includes three replicative pols, , , and ", and pol . Family X consists of pols , , , and terminal deoxynucleotidyl transferase (TdT), and family Y consists of pols , , , and REV1. Because not all functions of eukaryotic pols have been fully elucidated, selective inhibitors of pol families are useful tools for distinguishing pols and clarifying their biological functions. We have therefore been searching for natural compounds that selectively inhibit each of these eukaryotic pols. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Of mammalian pols, pol , an X-family pol, is the smallest molecule (39 kDa), does not form complexes, and has been solved only for crystal structure. Hence, three-dimensional docking studies on pol and some inhibitors are performed. We have found that many acidic compounds inhibited pol activity, and have explained that the free carboxy groups of the compounds, such as longer chain fatty acid 9) and lithocholic acid, 10) interacted with Lys35 of pol , which is a single-stranded DNA (ssDNA) binding amino acid, by hydrogen bonds, and then competitively inhibited the activity.
Here, we report novel compounds 1 and 2, isolated from a cultured medium of fungal strain derived from a petal and named trichoderonic acids A and B respectively (Fig. 1 ). These compounds are heptelidic acid analogs, produced by marine fungi, including Gliocladium virens, Chaetomium globosum, and Trichoderma viride. 20) The fungi, which are parasitic on plants, are perhaps the best screening sources for finding bioactive or novel compounds. These compounds are carboxylic acid compounds, and they selectively inhibited the activities of mammalian X-family pols, including pol .
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We report the isolation and structural determination of terpenoids 1 and 2 and their potential as anti-cancer chemotherapy agents.
Materials and Methods

Materials. Nucleotides, including [
3 H]-deoxythymidine 5 0 -triphosphate (dTTP) (43 Ci/mmol), and chemically synthesized DNA templates, including poly(dA), were purchased from GE Healthcare Bio-Sciences (Little Chalfont, UK). DNA primer, including oligo(dT) 18 , was customized by Sigma (Hokkaido, Japan). All other reagents were of analytical grade and were purchased from Wako Chemical Industries (Osaka, Japan).
Instrumental analysis.
1 H and 13 C NMR spectra were recorded on a Bruker DRX400 MHz. Chemical shifts were reported in , parts per million (ppm), relative to TMS as an internal standard, or were calibrated using residual undeuterated solvent as an internal reference. IR spectra were obtained on a Jasco FT/IR-41 spectrometer. Mass spectra were on an API QSTAR Pulsar I spectrometer using poly(ethylene glycol) as an internal standard. Optical rotations were measured on a Jasco P-1010 digital polarimeter. Column chromatography was carried out on Kanto Chemical Silica Gel 60N (spherical, neutral) (Tokyo, Japan). Analytical thin-layer chromatography (TLC) was performed on precoated silica gel 60 F254 plates (Merck & Co., Inc., Whitehouse Station, NJ, USA), and compounds were visualized by UV illumination (254 nm) or heating to 150 C after spraying of p-anisaldehyde in EtOH.
DNA polymerase and other DNA metabolic enzymes assays. Pols from mammals, a fish (cherry salmon), and a plant (cauliflower) were purified, and prokaryotic pols and other DNA metabolic enzymes were purchased as described in previous reports. 7, 8) The activities of all pols and other DNA metabolic enzymes were measured as described in previous reports. 7, 8, 21) The substrates of the pols were poly(dA)/oligo(dT) 18 and dTTP as DNA template-primer and dNTP (2 0 -deoxyribonucleoside 5 0 -triphosphate) substrate respectively. Compounds 1 and 2 were dissolved in dimethyl sulfoxide (DMSO) at various concentrations and sonicated for 30 s. The sonicated samples (4 ml) were mixed with 16 ml of each pol enzyme (final amount, 0.05 units) in 50 mM Tris-HCl (pH 7.5) containing 1 mM dithiothreitol, 50% glycerol, and 0.1 mM EDTA, and were kept at 0 C for 10 min. These inhibitor-enzyme mixtures (8 ml) were added to 16 ml of each standard enzyme reaction mixture (final concentration, 50 mM TrisHCl pH 7.5, 1 mM dithiothreitol, 1 mM MgCl 2 , 15% glycerol, 10 mM poly(dA)/oligo(dT) 18 , and 10 mM [
3 H]-dTTP), and incubation was carried out at 37 C for 60 min, except for Taq pol, which was incubated at 74 C for 60 min. The activity without the inhibitor was considered to be 100%, and the remaining activity at each concentration of the inhibitor was determined relative to this value. One unit of pol activity was defined as the amount of enzyme that catalyzed the incorporation of 1 nmol dNTP (dTTP) into the synthetic DNA template-primer (poly(dA)/oligo(dT) 18 , A/T ¼ 2=1) in 60 min at 37 C under normal reaction conditions for each enzyme (scintillation counts: approximately 1 pmol of incorporated radioactive nucleotides ¼ 100 cpm). 7, 8) Investigation of growth on cultured human cancer cells. Human cervix carcinoma cell line HeLa and human breast carcinoma cell line MCF-7 were obtained from the Health Science Research Bank (Osaka, Japan). These cells were cultured in Eagle's Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 mg/ml). The cells were cultured at 37 C in standard medium in a humidified atmosphere of 5% CO 2 -95% air. The cytotoxicity of the compound was investigated as follows: High concentrations (10 mM) of the compounds were dissolved in DMSO and stored. Approximately 5 Â 10 3 cells per well were inoculated into 96-well micro plates, and then the compound stock solution was diluted to various concentrations and applied to each well. After incubation for 24 h, the survival rate was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. 
Results
Isolation and cultivation of fungus Fungal strain IG34HB was isolated from flowers collected at Inage Seaside Park, Chiba Prefecture, Japan. The cultured medium of this strain had the strongest mammalian pol inhibitory activity of the isolated fungi media. The fungus was selected by culturing flower fragments on potato dextrose agar plates (Difco) and was transferred several times. The culture was incubated at 28 C. The fungus was identified as Trichoderma virens by TechnoSuruga Laboratory (Shizuoka, Japan). A small agar plug was then transferred into a 2-liters Erlenmeyer flask containing 1 liter of potato dextrose broth (24 g/l, Difco). Cultures of IG34HB strain (6 liters) were grown for 26 d without shaking in a dark place.
Extraction and purification of compounds
The culture broth of IG34HB strain (Trichoderma virens) was filtered through cheesecloth. The filtrated medium was extracted with CH 2 Cl 2 . The organic layer was evaporated in vacuo to obtain 932 mg of crude residue. The crude extract was screened for inhibitory activity against mammalian pols and separated into six fractions (A-F) by silica gel column chromatography by the 
Structure determination of isolated compounds
The molecular formula of compound 1 was determined to be C 16 H 24 O 6 (m=z found 335.1463 ½M þ Na þ , calcd for C 16 H 24 O 6 Na 335.1465) with a positive high resolution electrospray ionization mass spectrometer (HR-ESIMS) spectrum. Table 1 summarizes the 1 H, 13 C, and DEPT NMR spectra. The partial structure of compound 1, the bold-lined structure in Thus the planar structure of compound 1, named trichoderonic acid A, was fully established. The relative configurations of C-1, C-6, and C-7 were deduced to be H-1/H-6 anti and H-6/H-7 anti from the coupling constants (J 1;6 ¼ 12:8 Hz, J 6;7 ¼ 12:8 Hz), as well as NOESY cross-peak between H-1 and H-7. The NOESY cross-peak between H-6 and H-14 indicated that the methoxymethyl moiety was -oriented. Therefore, the relative structure of compound 1 was found to possess the (1S Ã ,6S Ã ,7R Ã ,10S Ã ) configuration. The molecular formula of compound 2 was determined as C 30 H 40 O 10 (m=z found 583.2509 ½M þ Na þ , calcd for C 30 H 40 O 10 Na 583.2513) with a positive HR-ESIMS spectrum and careful analysis of 1 H, 13 C, and DEPT NMR spectra, as summarized in Table 2 . The 1 H, 13 C, COSY, and HMBC NMR spectra suggested that compound 2 has partial structures 2a and 2b (Fig. 2) suggested the presence of an ester group, completing the determination of the structure of compound 2, named trichoderonic acid B.
The molecular formula of compound 3 was determined by the positive HR-ESIMS spectrum as C 15 H 20 O 5 (m=z found 303.1206 ðM þ NaÞ þ , calcd for C 15 H 20 O 5 Na 303.1202). Based on analyses of the NMR spectra and the mass spectrum, the structure of compound 3 was identified as (+)-heptelidic acid, which had been isolated from Gliocladium virens, as described by Itoh et al. Compounds 1 and 2 are naturally occurring compound 3 analogs (Fig. 1) . To determine whether never compounds 1 and 2 are generated from heptelidic acid under the acidic purification condition with AcOH, compound 3 was exposed to a condition similar to purification. Compound 3 in MeOH and AcOH (100:1, 2 ml) was stirred at 40 C for 24 h. No generation of compounds 1 and 2 was observed by TLC analysis. Hence, these compounds are not generated from compound 3 under the acidic purification condition.
Structure determination Trichoderonic acid A ((5aS
Ã ,6R Ã ,9S Ã ,9aS Ã )-9-hydroxy-6-isopropyl-9-(methoxymethyl)-1-oxo-1,3,5a,6,7,8,9,9a-octahydro-2-benzoxepine-4-carboxylic acid) ( 
Effects of isolated compounds on the activities of DNA polymerases and other DNA metabolic enzymes
First, the novel isolated compounds 1 and 2 and compound 3 were tested for inhibition of 10 mammalian pols by radiolabeled nucleotide incorporation assay. 7, 8) The pols tested included members of families A (pol ), B (pols , , and "), X (pols and and TdT), and Y (pols , , and ). As shown in Fig. 3A , these compounds at 200 mM were found to inhibit significantly the activities of all three X-family pols, and rat pol was the most strongly inhibited among the three pols. The inhibitory effect of compound 2 was more than 5-fold stronger than that of compound 1 or 3. Compound 2 inhibited the activity of these pols dose-dependently, and 50% inhibition of pols and and TdT was observed at concentrations of 41.6, 30.8, and 44.1 mM respectively (Fig. 4) . On the other hand, the activities of these compounds against members of other families (families A, B, and Y) of mammalian pols (Fig. 3A) , a fish pol (cherry salmon pol ), a higher plant pol (cauliflower pol ), and prokaryotic pols (the Klenow fragment of E. coli pol I, T4 pol, and Taq pol) (Fig. 3B) had no influence.
These compounds at the same concentration (200 mM) did not inhibit the activities of the other DNA metabolic enzymes, including calf primase pol , human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase, and bovine deoxyribonuclease I (DNase I) (Fig. 3C) . These results suggest that compounds 1 to 3 are selective inhibitors of mammalian X-family pols.
Since compound 2 was a significantly stronger inhibitor than compound 1 or 3, we concentrated our efforts on compound 2 in the latter part of this study. Effects of interaction of nucleic acid, protein, and compound 2
Next, to determine whether the inhibitor resulted in binding to DNA or enzymes, the interaction of compound 2 with double-stranded DNA (dsDNA) was investigated based on the thermal transition of dsDNA with and without the compound.
23) The Tm of dsDNA with an excess amount of compound 2 (200 mM) was measured using a spectrophotometer equipped with a thermoelectric cell holder. In the concentration range used, no thermal transition of Tm was observed, whereas ethidium bromide, used as a positive control, a typical intercalating compound, produced a clear thermal transition (data not shown). These results indicate that compound 2 did not intercalate to DNA as a templateprimer, and that the compound might directly bind to the enzyme and inhibit its activity.
To determine the effects of a non-ionic detergent on the binding of compound 2 to X family pols, such as pols , , and TdT, Nonidet P-40 (NP-40) was added to A, Mammalian pols; B, plant, fish, and prokaryotic pols; C, other DNA metabolic enzymes. Compounds 1 (white bars), 2 (black bars), and 3 (gray bars) (200 mM each) were incubated with each enzyme (0.05 units). Enzymatic activity was measured as described previously. 7, 8) Enzyme activity in the absence of the compounds was taken as 100%. Data are shown as the means AE SEM for four independent experiments. the reaction mixture at a concentration of 0.05 or 0.1%. In the absence of compound 2, the activities of these enzymes were not affected by the addition of NP-40, and we stipulated the activities in these cases to be 100%. The inhibitory effect of compound 2 at 30 mM was not reversed by the addition of 0.1% NP-40 to the reaction mixture (data not shown). These results suggest that compound 2 can bind to and interact with the hydrophilic region of the enzyme protein. We also tested whether an excess amount of a substrate DNA analog, poly(rC) (50 mM), or a protein, BSA (200 mg/ml), would prevent the inhibitory effects of compound 2. If the compound bound to the enzymes by non-specific adhesion, the addition of this nucleic acid or protein would be expected to reduce inhibitory activity. The fact that neither poly(rC) nor BSA had inhibitory effects on compound 2 suggests that the compound can occur selectively or bind to a specific site on the enzymes and not to the nucleic acid.
Mode of inhibition of family X pols by compound 2 To elucidate the mechanism by which compound 2 inhibited mammalian X-family pols, including pols , , and TdT, the extent of inhibition as a function of substrate concentration was studied. In kinetic analysis of pols and , poly(dA)/oligo(dT) 18 and dTTP were used as the DNA template-primer and the dNTP substrate respectively. Lineweaver-Burk double reciprocal plots of the results showed that compound 2-induced inhibition of rat pol activity was competitive with respect to both the DNA template-primer and the dNTP substrate (Table 3 ). In the case of the DNA template-primer, the apparent maximum velocity (V max ) was unchanged at 111 pmol/h, whereas 33.96 pmol/h of the Michaelis constant (K m ) increased in the presence of 30 mM of compound 2. The V max of the dNTP substrate was unchanged at 62.5 pmol/h, and the K m of the dNTP substrate increased from 3.05 to 16.7 mM in the presence of 30 mM of compound 2. The inhibition constant (K i ) values, obtained from Dixon plots, were found to be 6.4 mM and 8.5 mM for the DNA template-primer and the dNTP substrate respectively. As shown in Table 3 , inhibition of human pol activity was also competitive with respect to both the DNA template-primer (V max was unchanged at 83.3 pmol/h) and the dNTP substrate (V max was unchanged at 52.6 pmol/h). The inhibition constant (K i ) values were found to be 7.6 mM and 9.5 mM for the DNA template-primer and the dNTP substrate respectively.
In kinetic analysis of calf TdT, oligo(dT) 18 and dTTP were used as the DNA primer and dNTP substrate respectively, because they do not require template DNA. Double reciprocal plots of the results showed that compound 2-induced inhibition of calf TdT activity was competitive with respect to both the DNA primer and the dNTP substrate (Table 3 ). In the case of the DNA primer, V max was unchanged at 90.9 pmol/h, whereas more than 7-fold increases in K m were observed in the presence of 30 mM of compound 2. The V max of the dNTP substrate was unchanged at 55.6 pmol/h, and the K m of the dNTP substrate increased from 1.02 to 4.55 mM in the presence of 0 to 30 mM of compound 2. The inhibition constant (K i ) values, obtained from Dixon plots, were found to be 5.2 mM and 8.8 mM for the DNA primer and the dNTP substrate respectively.
The inhibition of pols and by compound 2 had the same kinetic mode as that of TdT, competitive with respect to both the DNA primer and the dNTP substrate, suggesting that the compound bound directly to both the DNA primer-binding site and the dNTP substratebinding site in family X of pols, and thus might directly inhibit the DNA polymerization process. Since the K i values for DNA (the template-primer for pols and or the primer of TdT) were smaller than those for the dNTP substrate, the affinity of compound 2 might be greater for the enzyme-nucleic acid complex than for the enzyme-nucleotide substrate binary complex. These Lineweaver-Burk plots and Dixon plots figures, based on Table 3 , are shown in supplemental Fig. 1 (see Biosci. Biotechnol. Biochem. Web site).
Inhibitory effects of compound 2 on cultured human cancer cells
Pols have recently emerged as important cellular targets of chemical intervention in the development of anti-cancer agents. 24) Novel isolated compound 2 can therefore be useful in chemotherapy, and we investigated the growth inhibitory effect of the compound against human cervical carcinoma cell line HeLa and human breast carcinoma cell line MCF-7.
As shown in Fig. 5 , compound 2 dose-dependently suppressed HeLa and MCF-7 cancer cell growth; the LD 50 values were 33.0 and 31.6 mM, respectively. The cell growth inhibition dose was the almost same as the pol inhibitory concentration (IC 50 value of compound 2 was 30.8 mM) (Fig. 4) . Compound 1 also prevented the growth of HeLa and MCF-7 cell lines, with LD 50 values of 165 and 158 mM respectively. On the other hand, these compounds did not influence the growth of normal human cells, such as such as HUVEC (human umbilical vein endothelial cells) and HDF (human dermal fibroblast) (data not shown), implying that the amount or activity of X-family pols in normal cells is significantly lower than that in cancer cells. Compound 2 was incubated with rat pol (square), human pol (circle), and calf TdT (triangle) (0.05 units of each). Pol activities were measured as described in ''Materials and Methods.'' Pol activity in the absence of the compounds was taken as 100%. Data are shown as the means AE SEM for three independent experiments.
Discussion
As described above, we found two novel terpenoids, trichoderonic acid A (1) and trichoderonic acid B (2), and (+)-heptelidic acid (3) (Fig. 1 ) in cultures of a fungus, Trichoderma virens. These compounds selectively inhibited the activity of mammalian family X of pols, and compound 2 showed potent and stronger effects in inhibiting the pols than compound 1 (Figs. 3  and 4) . Compounds 1 and 2 are considered to be synthesized from compound 3 in the fungal strain. Compound 3 was reported as antibiotic activity in anaerobic bacteria, 25) for example, and inhibitory activity of etoposide-induced apoptosis in human leukemia U937 cells. 26) The relationship between these known bioactivities and the inhibitory activity of X-family pols is unclear, and we will try to elucidate the in vivo effects of the compounds in pol inhibition in further studies.
Base excision repair (BER) is the major pathway involved in the removal of damaged bases, conserved from bacteria to eukaryotes. [27] [28] [29] [30] BER enzymes remove a damaged base-containing nucleotide, producing as a final step a single nucleotide gap that is filled by a pol and sealed by a DNA ligase. Of the various types of DNA damage, DNA double-strand breaks (DSB) are the most dangerous. These lesions frequently induce various chromosomal aberrations that can provoke carcinogenesis and cellular death. 31) Two pathways repair this kind of lesion: error-free homologous recombination, in which an intact double-stranded copy is used as a template to properly restore the broken ends by DNA synthesis, and error-prone non-homologous end joining (NHEJ), by which the DNA ends are held together and 18 The inhibitory mode of DNA template-primer was analyzed using reaction conditions of various concentrations (0.67-10 mM) of poly(dA)/oligo(dT) 18 and a high concentration (50 mM) of dTTP. The inhibitory mode of the dNTP substrate was analyzed using reaction conditions of various concentrations (0.5-10 mM) of dTTP and a high concentration (50 mM) of poly(dA)/oligo(dT) 18 . The amount of these X-family pols in the kinetic reaction mixture was 0.05 units (50 pmol/h). processed to yield ssDNA portions that are annealed with limited base pair homology, the resulting gap being further filled by a pol. 32) Pol is required for short-patch BER, a DNA repair pathway that is essential in repairing abasic sites. 33, 34) Pol is involved in NHEJ, a mechanism for rejoining DSB, coupled with BER. [35] [36] [37] [38] TdT is expressed only in lymphoid tissue, and adds nucleotides to double-strand breaks formed during V(D)J recombination, promoting immunological diversity. 3, 39) Inhibitors of X-family pols can be useful as anti-cancer drugs when combined with DNA-damaging agents. This combination therapy should cause an accumulation of gaps in the DNA of cancer cells, suppress cancer cell proliferation, and lead to apoptosis.
The overarching aim of this series of studies is to provide an alternative means of examining the roles of pol. 3, 4) To date, at least 15 pols have been identified in eukaryotes; [3] [4] [5] [6] [7] but many of the functions and properties of eukaryotic pols remain unclear because knockout of a pol gene usually results in an in vivo lethal mutant. In addition, most pols are large molecules that often form or participate in multimeric complexes, and these properties increase the difficulty of elucidating function by conventional structural analysis. The selective inhibitors of pol families are not only useful tools for distinguishing pols and clarifying their biological functions, but also may be potent anti-cancer drugs with no side effects. Over the last 15 years, we have screened for and reported many new inhibitors of eukaryotic pols from natural products. 40, 41) To our knowledge, there have been no reports on such natural inhibitors specific to X-family pols, such as pol , pol , and TdT, except for nodulisporol, nodulisporone, and hymenoic acid as pol -inhibitors, 15, 18) and kasanosins A and B as both pols and -inhibitors, 17) which we reported previously. The IC 50 values of compound 2, nodulisporol, nodulisporone, and hymenoic acid, against pol were 30.8, 168, 82, and 91.7 mM respectively; therefore, compound 2 was a stronger pol inhibitor than the other compounds. Compounds 1 and 2 differed from the other compounds in that these compounds inhibited all the pols of family X (pol , pol , and TdT) examined to date. As described above, we have succeeded in identifying novel pol inhibitors. Compounds 1 and 2 could be used as tools and molecular probes as polspecific inhibitors in studies to determine the precise roles of X-family pols in vitro and in vivo, since they bind directly to or interact with a target enzyme. These compounds might also provide valuable information for developing a drug design strategy for anti-cancer chemotherapy agents, because compounds 1 and 2 had no influence on the growth of normal human cultured cell lines.
